المؤلفون: Buchhorn de Freitas S; Center of Technological Development, Biotechnology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil; Department of Microbiology and Parasitology, Biology Institute, Federal University of Pelotas, Pelotas, RS, Brazil., Clair Pinto Seixas Neto A; Department of Microbiology and Parasitology, Biology Institute, Federal University of Pelotas, Pelotas, RS, Brazil., Aparecido Panagio L; Department of Microbiology, State University of Londrina, CEP 86057-970 Londrina, PR, Brazil., Pereira Soares M; Regional Diagnostic Laboratory, Veterinary College, Federal University of Pelotas, Pelotas, RS, Brazil., Drawanz Hartwig D; Center of Technological Development, Biotechnology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil; Department of Microbiology and Parasitology, Biology Institute, Federal University of Pelotas, Pelotas, RS, Brazil. Electronic address: daianehartwig@gmail.com.

المصدر: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3802-3810. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Mice, Inbred BALB C* , Silver*/administration & dosage , Silver*/pharmacology , Acinetobacter baumannii*/immunology , Acinetobacter baumannii*/drug effects , Acinetobacter Infections*/prevention & control , Acinetobacter Infections*/immunology , Metal Nanoparticles* , Adhesins, Bacterial*/immunology , Adjuvants, Immunologic*/administration & dosage , Adjuvants, Immunologic*/pharmacology , Antibodies, Bacterial*/blood , Antibodies, Bacterial*/immunology, Animals ; Mice ; Drug Resistance, Multiple, Bacterial ; Bacterial Vaccines/immunology ; Bacterial Vaccines/administration & dosage ; Alum Compounds/administration & dosage ; Female ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Disease Models, Animal

المؤلفون: Ghorbanzadeh B; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran. Electronic address: b_ghorbanzadeh82@yahoo.com., Azizolahi B; Department of Laboratory Sciences, School of Allied Medical Sciences, Dezful University of Medical Sciences, Dezful, Iran., Masoudipur F; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran., Boroun A; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran., Azizi M; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran., Oroojan AA; Department of Physiology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran., Jafrasteh S; Clinical Research Development Unit, Ganjavian Hospital, Dezful University of Medical Sciences, Dezful, Iran.

المصدر: Behavioural brain research [Behav Brain Res] 2024 Jul 09; Vol. 469, pp. 115065. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7549 (Electronic) Linking ISSN: 01664328 NLM ISO Abbreviation: Behav Brain Res Subsets: MEDLINE

مواضيع طبية MeSH: Acetaminophen*/pharmacology , Acetaminophen*/administration & dosage , Antidepressive Agents*/pharmacology , Antidepressive Agents*/administration & dosage , Naloxone*/pharmacology , Narcotic Antagonists*/pharmacology , Narcotic Antagonists*/administration & dosage , Dose-Response Relationship, Drug*, Animals ; Male ; Mice ; Swimming ; Depression/drug therapy ; Depression/metabolism ; Morphine/pharmacology ; Morphine/administration & dosage ; Hippocampus/drug effects ; Hippocampus/metabolism ; Disease Models, Animal ; Analgesics, Opioid/pharmacology ; Analgesics, Opioid/administration & dosage ; Analgesics, Non-Narcotic/pharmacology ; Analgesics, Non-Narcotic/administration & dosage ; Receptors, Opioid/metabolism ; Receptors, Opioid/drug effects ; Receptors, Opioid, mu/metabolism ; Receptors, Opioid, mu/drug effects

المؤلفون: Gupta AA; Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada. Electronic address: abha.gupta@uhn.ca., Xue W; COG Data Center, Gainesville, FL, USA., Harrison DJ; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hawkins DS; Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA., Dasgupta R; Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, USA., Wolden S; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shulkin B; St Jude Children's Research Hospital, Memphis, TN, USA., Qumseya A; COG Data Center, Gainesville, FL, USA., Routh JC; Department of Diagnostic Imaging, Duke University School of Medicine, Durham, NC, USA., MacDonald T; IWK Health Center, Halifax, NS, Canada., Feinberg S; Maimonides Cancer Center at Maimonides Medical Center and Children's Hospital, Brooklyn, NY, USA., Crompton B; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rudzinski ER; Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA., Arnold M; Children's Hospital of Colorado, Aurora, CO, USA., Venkatramani R; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.

المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Jul; Vol. 25 (7), pp. 912-921.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Sirolimus*/analogs & derivatives , Sirolimus*/administration & dosage , Sirolimus*/therapeutic use , Rhabdomyosarcoma*/drug therapy , Rhabdomyosarcoma*/mortality , Rhabdomyosarcoma*/pathology , Vincristine*/administration & dosage , Vincristine*/adverse effects , Cyclophosphamide*/administration & dosage, Humans ; Male ; Female ; Child ; Adolescent ; Child, Preschool ; Young Adult ; Adult ; Dactinomycin/administration & dosage ; Irinotecan/administration & dosage ; Irinotecan/therapeutic use ; Infant ; Progression-Free Survival ; Forkhead Box Protein O1/genetics

SCR Protocol: VAC protocol

المؤلفون: Luukkainen MEK; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.; Medical Research Center Oulu, Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland., Koivunen JP; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland; jussi.koivunen@pohde.fi.; Medical Research Center Oulu, Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.

المصدر: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 2805-2813.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Anaplastic Lymphoma Kinase*/antagonists & inhibitors , Anaplastic Lymphoma Kinase*/genetics , Anaplastic Lymphoma Kinase*/metabolism , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Protein Kinase Inhibitors*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Cisplatin*/pharmacology , Cisplatin*/administration & dosage , Pemetrexed*/pharmacology , Pemetrexed*/administration & dosage, Humans ; Cell Line, Tumor ; Apoptosis/drug effects ; Drug Synergism ; Drug Resistance, Neoplasm/drug effects ; Receptor Protein-Tyrosine Kinases/antagonists & inhibitors ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/metabolism ; Piperidines/pharmacology ; Piperidines/administration & dosage ; Carbazoles/pharmacology ; Carbazoles/administration & dosage

المؤلفون: Zheng Z; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China., Sun J; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China., Wang J; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China., He S; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China., Liu Z; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China., Xie J; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China., Yu CY; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China; Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha 410006, China. Electronic address: yucuiyunusc@hotmail.com., Wei H; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study & School of Pharmaceutical Science, Hengyang Medical School, University of South China, 28 W Changsheng Road, Hengyang 421001, Hunan, China. Electronic address: weih@usc.edu.cn.

المصدر: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Jul; Vol. 371, pp. 570-587. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

مواضيع طبية MeSH: Myocardial Infarction*/drug therapy , Myocardial Infarction*/metabolism , DNA, Mitochondrial* , Hydrogels*/administration & dosage , Hydrogels*/chemistry , Myocytes, Cardiac*/drug effects , Myocytes, Cardiac*/metabolism , Polymers*/chemistry , Polymers*/administration & dosage, Animals ; Male ; Indoles/administration & dosage ; Indoles/chemistry ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Chitosan/chemistry ; Chitosan/administration & dosage ; Rats, Sprague-Dawley ; Polyethylene Glycols/chemistry ; Polyethylene Glycols/administration & dosage ; Rats ; Membrane Proteins ; Reactive Oxygen Species/metabolism ; Boronic Acids ; Ginsenosides

المؤلفون: Rud CL; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark. Electronic address: charru@rm.dk., Hvistendahl MK; Department of Intestinal Failure and Liver Diseases, Rigshospitalet, 2100 Copenhagen, Denmark., Langdahl B; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark., Kraglund F; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus N, Denmark., Baunwall SMD; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus N, Denmark., Lal S; Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Salford, United Kingdom., Jeppesen PB; Department of Intestinal Failure and Liver Diseases, Rigshospitalet, 2100 Copenhagen, Denmark., Hvas CL; Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.

المصدر: Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2024 Jul; Vol. 43 (7), pp. 1747-1758. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8309603 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1983 (Electronic) Linking ISSN: 02615614 NLM ISO Abbreviation: Clin Nutr Subsets: MEDLINE

مواضيع طبية MeSH: Ileostomy* , Cross-Over Studies* , Whey Proteins*/administration & dosage , Rehydration Solutions*/administration & dosage , Fluid Therapy*/methods, Humans ; Double-Blind Method ; Male ; Female ; Middle Aged ; Aged ; Dehydration/therapy ; Caseins/administration & dosage ; Protein Hydrolysates/administration & dosage ; Adult

المؤلفون: James J; Harvard Combined Dermatology Residency Program, Department of Dermatology, Harvard Medical School, 55 Fruit Street, BH 616 Boston, MA 02114, USA., Otto T; Department of Dermatology, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA., Gao J; Department of Dermatology, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA., Porter ML; Department of Dermatology, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA; Department of Dermatology, Harvard Medical School, 3 Blackfan Cir, Boston, MA 02115, USA. Electronic address: clears@bidmc.harvard.edu.

المصدر: Dermatologic clinics [Dermatol Clin] 2024 Jul; Vol. 42 (3), pp. 357-363. Date of Electronic Publication: 2024 Apr 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 8300886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-0520 (Electronic) Linking ISSN: 07338635 NLM ISO Abbreviation: Dermatol Clin Subsets: MEDLINE

مواضيع طبية MeSH: Psoriasis*/drug therapy , Thalidomide*/analogs & derivatives , Thalidomide*/therapeutic use , Acitretin*/therapeutic use , Acitretin*/administration & dosage , Immunosuppressive Agents*/therapeutic use , Methotrexate*/therapeutic use , Methotrexate*/administration & dosage , Cyclosporine*/therapeutic use , Cyclosporine*/administration & dosage , Dermatologic Agents*/therapeutic use , Dermatologic Agents*/administration & dosage, Humans ; Administration, Oral ; Piperidines/therapeutic use ; Piperidines/administration & dosage ; Pyrazoles/therapeutic use ; Pyrimidines/therapeutic use ; Pyrroles/therapeutic use ; Pyrroles/administration & dosage ; Antibodies, Monoclonal, Humanized/therapeutic use ; Keratolytic Agents/therapeutic use ; Indoles/therapeutic use ; Nicotinic Acids/therapeutic use ; Nicotinic Acids/administration & dosage ; Antibodies, Monoclonal

المؤلفون: Esih H; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Graduate School of Biomedicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Mezgec K; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Graduate School of Biomedicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Billmeier M; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Malenšek Š; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Graduate School of Biomedicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Benčina M; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Centre for Technologies of Gene and Cell Therapy, 1000 Ljubljana, Slovenia., Grilc B; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, Ljubljana 1000, Slovenia., Vidmar S; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Graduate School of Biomedicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Gašperlin M; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, Ljubljana 1000, Slovenia., Bele M; Department of Materials Chemistry, National Institute of Chemistry, Ljubljana 1000, Slovenia., Zidarn M; University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia., Zupanc TL; University Medical Center Ljubljana, 1000 Ljubljana, Slovenia., Morgan T; University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia., Jordan I; Applied Science & Technologies, ProBioGen AG, Berlin, Germany., Sandig V; Applied Science & Technologies, ProBioGen AG, Berlin, Germany., Schrödel S; SIRION Biotech GmbH, Am Klopferspitz 19, 82152 Martinsried, Germany., Thirion C; SIRION Biotech GmbH, Am Klopferspitz 19, 82152 Martinsried, Germany., Protzer U; Institute of Virology, School of Medicine, Technical University of Munich, Helmholtz Zentrum München, Munich, Germany., Wagner R; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany; Institute of Clinical Microbiology & Hygiene, University Hospital, Regensburg, Germany., Lainšček D; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Centre for Technologies of Gene and Cell Therapy, 1000 Ljubljana, Slovenia. Electronic address: dusko.lainscek@ki.si., Jerala R; Department of Synthetic Biology and Immunology, National Institute of Chemistry, 1000 Ljubljana, Slovenia; Centre for Technologies of Gene and Cell Therapy, 1000 Ljubljana, Slovenia. Electronic address: roman.jerala@ki.si.

المصدر: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Jul; Vol. 371, pp. 179-192. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Vaccines*/administration & dosage , COVID-19 Vaccines*/immunology , Nanoparticles*/administration & dosage, Animals ; Administration, Oral ; Mouth Mucosa/immunology ; COVID-19/prevention & control ; Female ; Mice, Inbred BALB C ; SARS-CoV-2/immunology ; Mice ; Drug Delivery Systems/methods ; Humans ; Lipids/chemistry ; Lipids/administration & dosage ; RNA, Messenger/administration & dosage ; Liposomes

المؤلفون: Oga T; Department of Respiratory Medicine, Kawasaki Medical School, 577, Matsushima, Kurashiki, Okayama, 701-0192, Japan. Electronic address: ogato@med.kawasaki-m.ac.jp., Mita C; Value Evidence and Outcomes, Japan Medical and Development, GSK, 1-8-1 Akasaka, Minato-ku, Tokyo 107-0052, Japan., Ito R; Value Evidence and Outcomes, Japan Medical and Development, GSK, 1-8-1 Akasaka, Minato-ku, Tokyo 107-0052, Japan., Requena G; Global Value Evidence and Outcomes, Epidemiology, GSK, 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK., Rothnie KJ; Global Value Evidence and Outcomes, Epidemiology, GSK, 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK., Noorduyn SG; Value Evidence and Outcomes, 100 Milverton Drive, Suite 800, Mississauga, Ontario, L5R 4H1, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main St W, Hamilton, Ontario, L8S 4L8, Canada., Yuanita L; Medical Affairs Asthma & COPD, Japan Medical and Development, GSK, 1-8-1 Akasaka, Minato-ku, Tokyo 107-0052, Japan., Yarita M; Value Evidence and Outcomes, Japan Medical and Development, GSK, 1-8-1 Akasaka, Minato-ku, Tokyo 107-0052, Japan.

المصدر: Respiratory investigation [Respir Investig] 2024 Jul; Vol. 62 (4), pp. 685-694. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

مواضيع طبية MeSH: Benzyl Alcohols*/administration & dosage , Chlorobenzenes*/administration & dosage , Asthma*/drug therapy , Quinuclidines*/administration & dosage , Androstadienes*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Japan ; Adult ; Administration, Inhalation ; Aged ; Drug Combinations ; Muscarinic Antagonists/administration & dosage ; Adrenergic beta-2 Receptor Agonists/administration & dosage ; Nebulizers and Vaporizers ; Adolescent ; Young Adult ; Drug Therapy, Combination ; Glycopyrrolate/administration & dosage ; Quinolones/administration & dosage

مؤلفون مشاركون: D2EFT Study Group

المصدر: The lancet. HIV [Lancet HIV] 2024 Jul; Vol. 11 (7), pp. e436-e448. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase IV; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

مواضيع طبية MeSH: Darunavir*/therapeutic use , Darunavir*/administration & dosage , HIV Infections*/drug therapy , HIV Infections*/virology , Oxazines* , Pyridones* , HIV-1*/drug effects , Heterocyclic Compounds, 3-Ring*/administration & dosage , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/adverse effects , Viral Load*/drug effects , Piperazines* , Reverse Transcriptase Inhibitors*/therapeutic use , Reverse Transcriptase Inhibitors*/administration & dosage , Ritonavir*/therapeutic use , Ritonavir*/administration & dosage, Humans ; Female ; Adult ; Male ; Middle Aged ; Standard of Care ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/administration & dosage ; Drug Therapy, Combination ; Emtricitabine/therapeutic use ; Emtricitabine/administration & dosage ; Treatment Outcome ; Antiretroviral Therapy, Highly Active ; Tenofovir/therapeutic use ; Tenofovir/administration & dosage ; CD4 Lymphocyte Count ; Treatment Failure ; Lamivudine/therapeutic use ; Lamivudine/administration & dosage